{"Title": ["Double Your Money with This Biotech", "ARDX Jumps On PHREEDOM Data, AXSM Is Awesome, CARA On Watch", "Why Ardelyx Shares Jumped Today", "5 Top Gainers In Healthcare Sector (HEPA, ARDX, PTI...)", "New Drugs Approved In September", "Why Ardelyx Shares Are Sinking Today", "6 Top Gainers In Healthcare Sector (ACAD, ARDX, KOOL\u2026)", "Why Ardelyx Shares Are Sinking Today", "Double Your Money with This Biotech", "5 Top Gainers In Healthcare Sector (ARDX, CDTX, EBS...)", "Why Ardelyx Is Soaring Today", "Ardelyx: AMPLIFY Study Meets Primary, All Key Secondary Endpoints - Quick Facts", "5 Biggest New Drug Approvals Potentially on the Way in 2019", "Health Care Sector Update for 03/08/2019: SEEL, ACET, ARDX, JNJ, PFE, ABT, MRK, AMGN", "What's in Store for Penumbra (PEN) This Earnings Season?", "Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?", "Two Down, Two To Go For Ardelyx", "Health Care Sector Update for 05/23/2018: AGIO,ARDX,RMTI,ACHV", "Health Care Sector Update for 05/23/2018: ACHV,ARDX,RMTI", "Why Ardelyx Inc. Is Down by Double Digits for a Second Day in a Row", "Here's Why Tiny Biotech Ardelyx Saw a Big Decline Today", "5 Great Breakout Stocks Offering Superlative Returns", "Zacks.com highlights: Sanchez Midstream Partners, Tecnoglass, Aeterna Zentaris, Ardelyx and Matrix Service", "5 Great Breakout Stocks Offering Superlative Returns", "Pre-Market Most Active for May 23, 2018 : TVIX, MU, CHK, AZN, ARDX, CADE, QQQ, TIF, SBGL, DB, CARA, TLT", "Health Care Sector Update for 01/03/2018: JNJ, PFE, ABT, MRK, AMGN, EGLT, ARDX, NTEC, PTN, UTHR", "Why Ardelyx (ARDX) Could Beat Earnings Estimates Again", "Zacks.com featured highlights: Akari Therapeutics, Joint, Tailored Brands, Ardelyx and BioTime", "5 Affordable Breakout Stocks Offering Excellent Returns", "Health Care Sector Update for 11/21/2017: JNJ, PFE, ABT, MRK, AMGN, ARDX, MDT, NVO", "Health Care Sector Update for 11/21/2017: ARDX,CLSN,BPMX", "10 Cheap Stocks to Buy With Only $12", "Can The Uptrend Continue for Ardelyx (ARDX)?", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Noteworthy Thursday Option Activity: SFM, TWTR, ARDX", "Ardelyx IBS-C Candidate Succeeds in Pivotal Study, Stock Up", "Pre-Market Most Active for Oct 12, 2017 : MU, AZN, ACRX, ARDX, INFI, JILL, BAC, C, GSK, SNAP, MNKD, TVIX", "Why Ardelyx Inc Skyrocketed Higher Today", "Why Spartan Motors, Ardelyx, and Glu Mobile Jumped Today", "Health Care Sector Update for 10/12/2017: ARDX,INFI,ACRX", "3 Small-Cap Biotech Stocks That Could Double In 2018", "Zacks.com featured highlights: Ardelyx, Novavax, BioScrip, Layne Christensen and Resonant", "5 Breakout Stocks Offering Phenomenal Returns", "With Ardelyx's Fall, Does Synergy Now Have a Clear Path to Victory?", "Health Care Sector Update for 05/12/2017: ARDX,TEAR,CAPR", "Friday's ETF with Unusual Volume: VNQI", "Ardelyx (ARDX) Worth Watching: Stock Rises 6.1% in Session", "Ardelyx (ARDX) Catches Eye: Stock Moves 14.2% Higher", "Catalyst (CPRX) Shows Strength: Stock Adds 9.6% in Session", "Friday's ETF Movers: IBB, GDXJ", "Health Care Sector Update for 07/15/2016: ALR,ARDX,CYTR", "Ardelyx (ARDX) Shares March Higher, Can It Continue?", "How The Parts Add Up: IBB Targets $388", "How Ardelyx (ARDX) Stock Stands Out in a Strong Industry", "Pre-Market Earnings Report for March 4, 2016 : SPLS, BIG, ARDX, TAX, EXK, MRCC", "Ardelyx (ARDX) Rises: Stock Adds 6.2% in Session", "Health Care Sector Update for 07/15/2016: IRWD,AGN,ARDX,CYTR", "How Ardelyx (ARDX) Stock Stands Out in a Strong Industry", "Can Ardelyx (ARDX) Run Higher on Strong Earnings Estimate Revisions?", "Should You Get Rid of Affimed N.V. (AFMD) Now?", "New Strong Buy Stocks for August 13th", "Why Earnings Season Could Be Great for Ardelyx (ARDX)", "Pre-Market Earnings Report for August 12, 2015 : M, ARMK, MRKT, FLO, CAE, AIT, STKL, EZCH, ARDX, ENZY, SMED, CRWS", "Can Teladoc (TDOC) Pull a Surprise this Earnings Season? - Analyst Blog", "Health Care Sector Update for 01/07/2016: ARDX, BIOC, TLOG", "Ardelyx (ARDX) is Overbought: Is A Drop Coming? - Tale of the Tape", "Ardelyx (ARDX) in Focus: Stock Moves 15.9% Higher - Tale of the Tape", "New Strong Sell Stocks for June 8th - Tale of the Tape", "Ardelyx Regains Product Portfolio Rights from AstraZeneca - Analyst Blog", "Health Care Sector Update for 06/03/2015: ARDX,AZN,BLFS,THC", "Strength Seen in Ardelyx (ARDX): Stock Rises 15.3% - Tale of the Tape", "Akers Biosciences (AKER): What to Expect in Q2 Earnings? - Analyst Blog", "Weakness Seen in Ardelyx (ARDX): Stock Plunges 28.7% - Tale of the Tape", "Tuesday Sector Laggards: Drugs, Biotechnology Stocks", "Why Ardelyx, Inc. Shares Plummeted Today", "Ardelyx (ARDX) Catches Eye: Stock Gains 5.2% - Tale of the Tape", "Weakness Seen in Ardelyx (ARDX): Stock Tumbles 9.5% - Tale of the Tape", "Kidney failure biotech Proteon Therapeutics sets terms for $61 million IPO", "Ardelyx (ARDX) Worth Watching: Stock Moves 16% Higher - Tale of the Tape", "5 Stocks With Jaw-Dropping Growth Potential", "Sector Update: Health Care", "Kidney failure biotech Proteon Therapeutics files for a $69 million IPO", "Ardelyx prices upsized IPO at $14 midpoint", "12 US IPOs planned for the week of Jun 16", "Small molecule biotech Ardelyx sets terms for $50 million IPO", "Sector Update: Health-Care Shares Mixed Pre-Market"], "Elapsed Time": ["JAN 24, 2020", "DEC 4, 2019", "DEC 3, 2019", "NOV 26, 2019", "OCT 4, 2019", "SEP 13, 2019", "SEP 9, 2019", "SEP 4, 2019", "JAN 24, 2020", "SEP 3, 2019", "SEP 3, 2019", "SEP 3, 2019", "AUG 19, 2019", "MAR 8, 2019", "AUG 6, 2018", "AUG 2, 2018", "SEP 4, 2019", "MAY 23, 2018", "MAY 23, 2018", "MAY 23, 2018", "MAY 22, 2018", "JAN 29, 2018", "JAN 19, 2018", "JAN 18, 2018", "MAY 23, 2018", "JAN 3, 2018", "DEC 26, 2017", "DEC 1, 2017", "NOV 30, 2017", "NOV 21, 2017", "NOV 21, 2017", "NOV 1, 2017", "JAN 4, 2018", "OCT 14, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 17, 2017", "JUL 10, 2017", "JUL 7, 2017", "MAY 29, 2017", "MAY 12, 2017", "JAN 6, 2017", "SEP 28, 2016", "JUL 18, 2016", "JUL 12, 2017", "JUL 15, 2016", "JUL 15, 2016", "JUL 12, 2016", "APR 21, 2016", "MAR 22, 2016", "MAR 3, 2016", "JAN 11, 2016", "JUL 15, 2016", "SEP 11, 2015", "SEP 10, 2015", "AUG 14, 2015", "AUG 13, 2015", "AUG 11, 2015", "AUG 11, 2015", "AUG 10, 2015", "JAN 7, 2016", "JUL 28, 2015", "JUN 16, 2015", "JUN 8, 2015", "JUN 4, 2015", "JUN 3, 2015", "MAY 20, 2015", "AUG 7, 2015", "FEB 3, 2015", "FEB 3, 2015", "FEB 3, 2015", "JAN 23, 2015", "OCT 10, 2014", "OCT 7, 2014", "OCT 6, 2014", "FEB 28, 2015", "OCT 1, 2014", "SEP 16, 2014", "JUN 19, 2014", "JUN 16, 2014", "JUN 9, 2014", "OCT 1, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/double-your-money-with-this-biotech-2020-01-24", "https://www.nasdaq.com/articles/ardx-jumps-on-phreedom-data-axsm-is-awesome-cara-on-watch-2019-12-04", "https://www.nasdaq.com/articles/why-ardelyx-shares-jumped-today-2019-12-03", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-hepa-ardx-pti...-2019-11-26", "https://www.nasdaq.com/articles/new-drugs-approved-in-september-2019-10-04", "https://www.nasdaq.com/articles/why-ardelyx-shares-are-sinking-today-2019-09-13", "https://www.nasdaq.com/articles/6-top-gainers-in-healthcare-sector-acad-ardx-kool...-2019-09-09", "https://www.nasdaq.com/articles/why-ardelyx-shares-are-sinking-today-2019-09-04", "https://www.nasdaq.com/articles/double-your-money-with-this-biotech-2020-01-24", "https://www.nasdaq.com/articles/5-top-gainers-in-healthcare-sector-ardx-cdtx-ebs...-2019-09-03", "https://www.nasdaq.com/articles/why-ardelyx-is-soaring-today-2019-09-03", "https://www.nasdaq.com/articles/ardelyx%3A-amplify-study-meets-primary-all-key-secondary-endpoints-quick-facts-2019-09-03", "https://www.nasdaq.com/articles/5-biggest-new-drug-approvals-potentially-on-the-way-in-2019-2019-08-19", "https://www.nasdaq.com/articles/health-care-sector-update-03082019-seel-acet-ardx-jnj-pfe-abt-mrk-amgn-2019-03-08", "https://www.nasdaq.com/articles/whats-in-store-for-penumbra-pen-this-earnings-season-2018-08-06", "https://www.nasdaq.com/articles/can-dental-growth-drive-henry-scheins-hsic-q2-earnings-2018-08-02", "https://www.nasdaq.com/articles/two-down-two-to-go-for-ardelyx-2019-09-04", "https://www.nasdaq.com/articles/health-care-sector-update-05232018-agioardxrmtiachv-2018-05-23", "https://www.nasdaq.com/articles/health-care-sector-update-05232018-achvardxrmti-2018-05-23", "https://www.nasdaq.com/articles/why-ardelyx-inc-down-double-digits-second-day-row-2018-05-23", "https://www.nasdaq.com/articles/heres-why-tiny-biotech-ardelyx-saw-big-decline-today-2018-05-22", "https://www.nasdaq.com/articles/5-great-breakout-stocks-offering-superlative-returns-2018-01-29", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-sanchez-midstream-partners-tecnoglass-aeterna-zentaris-ardelyx-and", "https://www.nasdaq.com/articles/5-great-breakout-stocks-offering-superlative-returns-2018-01-18", "https://www.nasdaq.com/articles/pre-market-most-active-may-23-2018-tvix-mu-chk-azn-ardx-cade-qqq-tif-sbgl-db-cara-tlt-2018", "https://www.nasdaq.com/articles/health-care-sector-update-01032018-jnj-pfe-abt-mrk-amgn-eglt-ardx-ntec-ptn-uthr-2018-01-03", "https://www.nasdaq.com/articles/why-ardelyx-ardx-could-beat-earnings-estimates-again-2017-12-26", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-akari-therapeutics-joint-tailored-brands-ardelyx-and", "https://www.nasdaq.com/articles/5-affordable-breakout-stocks-offering-excellent-returns-2017-11-30", "https://www.nasdaq.com/articles/health-care-sector-update-11212017-jnj-pfe-abt-mrk-amgn-ardx-mdt-nvo-2017-11-21", "https://www.nasdaq.com/articles/health-care-sector-update-11212017-ardxclsnbpmx-2017-11-21", "https://www.nasdaq.com/articles/10-cheap-stocks-to-buy-with-only-%2412-2017-11-01", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-ardelyx-ardx-2018-01-04", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2017-10-14", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-sfm-twtr-ardx-2017-10-12", "https://www.nasdaq.com/articles/ardelyx-ibs-c-candidate-succeeds-in-pivotal-study-stock-up-2017-10-12", "https://www.nasdaq.com/articles/pre-market-most-active-oct-12-2017-mu-azn-acrx-ardx-infi-jill-bac-c-gsk-snap-mnkd-tvix", "https://www.nasdaq.com/articles/why-ardelyx-inc-skyrocketed-higher-today-2017-10-12", "https://www.nasdaq.com/articles/why-spartan-motors-ardelyx-and-glu-mobile-jumped-today-2017-10-12", "https://www.nasdaq.com/articles/health-care-sector-update-10122017-ardxinfiacrx-2017-10-12", "https://www.nasdaq.com/articles/3-small-cap-biotech-stocks-that-could-double-in-2018-2017-10-17", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-ardelyx-novavax-bioscrip-layne-christensen-and-resonant", "https://www.nasdaq.com/articles/5-breakout-stocks-offering-phenomenal-returns-2017-07-07", "https://www.nasdaq.com/articles/ardelyxs-fall-does-synergy-now-have-clear-path-victory-2017-05-29", "https://www.nasdaq.com/articles/health-care-sector-update-05122017-ardxtearcapr-2017-05-12", "https://www.nasdaq.com/articles/fridays-etf-unusual-volume-vnqi-2017-01-06", "https://www.nasdaq.com/articles/ardelyx-ardx-worth-watching%3A-stock-rises-6.1-in-session-2016-09-28", "https://www.nasdaq.com/articles/ardelyx-ardx-catches-eye%3A-stock-moves-14.2-higher-2016-07-18", "https://www.nasdaq.com/articles/catalyst-cprx-shows-strength%3A-stock-adds-9.6-in-session-2017-07-12", "https://www.nasdaq.com/articles/fridays-etf-movers-ibb-gdxj-2016-07-15", "https://www.nasdaq.com/articles/health-care-sector-update-07152016-alrardxcytr-2016-07-15", "https://www.nasdaq.com/articles/ardelyx-ardx-shares-march-higher-can-it-continue-2016-07-12", "https://www.nasdaq.com/articles/how-parts-add-ibb-targets-388-2016-04-21", "https://www.nasdaq.com/articles/how-ardelyx-ardx-stock-stands-out-in-a-strong-industry-2016-03-22", "https://www.nasdaq.com/articles/pre-market-earnings-report-march-4-2016-spls-big-ardx-tax-exk-mrcc-2016-03-03", "https://www.nasdaq.com/articles/ardelyx-ardx-rises%3A-stock-adds-6.2-in-session-2016-01-11", "https://www.nasdaq.com/articles/health-care-sector-update-07152016-irwdagnardxcytr-2016-07-15", "https://www.nasdaq.com/articles/how-ardelyx-ardx-stock-stands-out-in-a-strong-industry-2015-09-11", "https://www.nasdaq.com/articles/can-ardelyx-ardx-run-higher-on-strong-earnings-estimate-revisions-2015-09-10", "https://www.nasdaq.com/articles/should-you-get-rid-of-affimed-n.v.-afmd-now-2015-08-14", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-august-13th-2015-08-13", "https://www.nasdaq.com/articles/why-earnings-season-could-be-great-for-ardelyx-ardx-2015-08-11", "https://www.nasdaq.com/articles/pre-market-earnings-report-august-12-2015-m-armk-mrkt-flo-cae-ait-stkl-ezch-ardx-enzy-smed", "https://www.nasdaq.com/articles/can-teladoc-tdoc-pull-a-surprise-this-earnings-season-analyst-blog-2015-08-10", "https://www.nasdaq.com/articles/health-care-sector-update-01072016-ardx-bioc-tlog-2016-01-07", "https://www.nasdaq.com/articles/ardelyx-ardx-is-overbought%3A-is-a-drop-coming-tale-of-the-tape-2015-07-28", "https://www.nasdaq.com/articles/ardelyx-ardx-in-focus%3A-stock-moves-15.9-higher-tale-of-the-tape-2015-06-16", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-june-8th-tale-of-the-tape-2015-06-08", "https://www.nasdaq.com/articles/ardelyx-regains-product-portfolio-rights-from-astrazeneca-analyst-blog-2015-06-04", "https://www.nasdaq.com/articles/health-care-sector-update-06032015-ardxaznblfsthc-2015-06-03", "https://www.nasdaq.com/articles/strength-seen-in-ardelyx-ardx%3A-stock-rises-15.3-tale-of-the-tape-2015-05-20", "https://www.nasdaq.com/articles/akers-biosciences-aker%3A-what-to-expect-in-q2-earnings-analyst-blog-2015-08-07", "https://www.nasdaq.com/articles/weakness-seen-in-ardelyx-ardx%3A-stock-plunges-28.7-tale-of-the-tape-2015-02-03", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-biotechnology-stocks-2015-02-03", "https://www.nasdaq.com/articles/why-ardelyx-inc-shares-plummeted-today-2015-02-03", "https://www.nasdaq.com/articles/ardelyx-ardx-catches-eye%3A-stock-gains-5.2-tale-of-the-tape-2015-01-23", "https://www.nasdaq.com/articles/weakness-seen-in-ardelyx-ardx%3A-stock-tumbles-9.5-tale-of-the-tape-2014-10-10", "https://www.nasdaq.com/articles/kidney-failure-biotech-proteon-therapeutics-sets-terms-61-million-ipo-2014-10-07", "https://www.nasdaq.com/articles/ardelyx-ardx-worth-watching%3A-stock-moves-16-higher-tale-of-the-tape-2014-10-06", "https://www.nasdaq.com/articles/5-stocks-jaw-dropping-growth-potential-2015-02-28", "https://www.nasdaq.com/articles/sector-update-health-care-2014-10-01", "https://www.nasdaq.com/articles/kidney-failure-biotech-proteon-therapeutics-files-69-million-ipo-2014-09-16", "https://www.nasdaq.com/articles/ardelyx-prices-upsized-ipo-14-midpoint-2014-06-19", "https://www.nasdaq.com/articles/12-us-ipos-planned-week-jun-16-2014-06-16", "https://www.nasdaq.com/articles/small-molecule-biotech-ardelyx-sets-terms-50-million-ipo-2014-06-09", "https://www.nasdaq.com/articles/sector-update-health-care-shares-mixed-pre-market-2014-10-01"], "Content": []}